BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34296805)

  • 21. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
    Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
    Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
    Maskin CR; Raman R; Houvras Y
    Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.
    Liu Z; Chen K; Dai J; Xu P; Sun W; Liu W; Zhao Z; Bennett SP; Li P; Ma T; Lin Y; Kawakami A; Yu J; Wang F; Wang C; Li M; Chase P; Hodder P; Spicer TP; Scampavia L; Cao C; Pan L; Dong J; Chen Y; Yu B; Guo M; Fang P; Fisher DE; Wang J
    Cell Res; 2023 Jan; 33(1):55-70. PubMed ID: 36588115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
    Konieczkowski DJ; Johannessen CM; Abudayyeh O; Kim JW; Cooper ZA; Piris A; Frederick DT; Barzily-Rokni M; Straussman R; Haq R; Fisher DE; Mesirov JP; Hahn WC; Flaherty KT; Wargo JA; Tamayo P; Garraway LA
    Cancer Discov; 2014 Jul; 4(7):816-27. PubMed ID: 24771846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
    Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
    Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MITF Modulates Therapeutic Resistance through EGFR Signaling.
    Ji Z; Erin Chen Y; Kumar R; Taylor M; Jenny Njauw CN; Miao B; Frederick DT; Wargo JA; Flaherty KT; Jönsson G; Tsao H
    J Invest Dermatol; 2015 Jul; 135(7):1863-1872. PubMed ID: 25789707
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
    Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
    [No Abstract]   [Full Text] [Related]  

  • 35. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBXW7 regulates a mitochondrial transcription program by modulating MITF.
    Abbate F; Badal B; Mendelson K; Aydin IT; Serasinghe MN; Iqbal R; Mohammed JN; Solovyov A; Greenbaum BD; Chipuk JE; Celebi JT
    Pigment Cell Melanoma Res; 2018 Sep; 31(5):636-640. PubMed ID: 29665239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
    Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
    PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
    Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
    Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.